Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 1.840 USD | -0.54% |
|
-6.12% | -36.11% |
| Market Cap | 6.17M 5.41M 5.11M 4.66M 8.72M 591M 8.78M 61.16M 23.69M 302M 23.16M 22.65M 971M | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 630K 553K 522K 476K 891K 60.41M 898K 6.25M 2.42M 30.86M 2.37M 2.32M 99.19M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | -0.54% | ||
| 1 week | -6.12% | ||
| Current month | -10.24% | ||
| 1 month | -12.80% | ||
| 3 months | -1.08% | ||
| 6 months | -24.28% | ||
| Current year | -36.11% |
| 1 week | 1.8 |  | 2.02 |
| 1 month | 1.8 | | 2.18 |
| Current year | 1.67 | | 3.8 |
| 1 year | 1.67 | | 14.24 |
| 3 years | 1.67 | | 450 |
| 5 years | 1.67 | | 4,495.35 |
| 10 years | 1.67 | | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 2023-08-07 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 2011-03-28 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 2017-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 2011-03-28 |
Justin Yorke
CHM | Chairman | 60 | 2022-08-15 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 2020-02-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/26 | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 7/26/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 7/26/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.54% | -6.12% | -65.45% | -98.60% | 6.17M | |
| -3.30% | +1.50% | +57.79% | +85.24% | 72.26B | |
| +1.25% | -3.01% | +37.83% | +84.34% | 60.24B | |
| +2.08% | +1.98% | +36.49% | +22.56% | 27.73B | |
| -3.06% | -1.81% | -14.01% | +354.94% | 25.73B | |
| -0.75% | +2.56% | +0.45% | -4.46% | 24.75B | |
| +0.40% | +0.75% | +23.72% | -9.50% | 20.74B | |
| -1.70% | -2.12% | +150.24% | +323.16% | 15.06B | |
| +0.36% | -0.34% | +48.98% | +162.10% | 14.41B | |
| -1.80% | -7.67% | -7.67% | +486.67% | 14.23B | |
| Average | -0.74% | -0.22% | +26.84% | +140.65% | 27.52B | |
| Weighted average by Cap. | -0.90% | +0.31% | +38.05% | +126.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.4M -9.82M -8.95M -16.75M -1.14B -16.87M -118M -45.52M -580M -44.49M -43.53M -1.86B | -13.56M -11.9M -11.24M -10.24M -19.18M -1.3B -19.31M -135M -52.1M -664M -50.93M -49.83M -2.13B |
| Net Debt | -1.12M -981K -926K -844K -1.58M -107M -1.59M -11.09M -4.29M -54.73M -4.2M -4.11M -176M | -5.54M -4.86M -4.59M -4.18M -7.83M -531M -7.88M -54.91M -21.27M -271M -20.79M -20.34M -871M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | US$1.840 | -0.54% | 8,536 |
| 26-09-24 | US$1.850 | -2.12% | 5,146 |
| 26-09-23 | US$1.890 | +0.53% | 4,740 |
| 26-09-22 | US$1.880 | +2.17% | 74,522 |
| 26-09-21 | US$1.840 | -6.12% | 16,472 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
